TD Health Sciences Fund - D Series (TDB3099)

TD Health Sciences Fund - D Series (TDB3099 $23.21)
- $23.21 P/E (TTM): 23.7X Cap: $364M
- View TDB3099 Profile
- View Questions on TDB3099

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Teladoc Health Inc. (TDOC $4.73)
- $4.73 Cap: $871M
- View TDOC Profile
- View Questions on TDOC
TD Health Sciences Fund - D Series (TDB3099 $23.21)
- $23.21 P/E (TTM): 23.7X Cap: $364M
- View TDB3099 Profile
- View Questions on TDB3099

Q: I recently asked if there was a better replacement. You answered with a US traded ETF. I should of said it needs to be a Canadian ETF.

Thank You

Read Answer Asked by Greg on January 26, 2026

iShares Core S&P Mid-Cap ETF (IJH $69.53)
- $69.53 P/E (TTM): 19.93X Cap: $109.16B
- View IJH Profile
- View Questions on IJH
TD U.S. Mid-Cap Growth Fund - D Series (TDB3093 $21.35)
- $21.35 P/E (TTM): 23.1X Cap: $152M
- View TDB3093 Profile
- View Questions on TDB3093
TD Health Sciences Fund - D Series (TDB3099 $23.21)
- $23.21 P/E (TTM): 23.7X Cap: $364M
- View TDB3099 Profile
- View Questions on TDB3099
Mulvihill U.S. Health Care Enhanced Yield ETF (XLVE $7.79)
- $7.79 P/E (TTM): 40.84X
- View XLVE Profile
- View Questions on XLVE

Q: What is your opinion of these 2 mutual funds. I have held for years but wondering if there is a better ETF to move the funds into or just keep theses two funds. They are held in a RRSP. Thanks

Read Answer Asked by Greg on January 15, 2026

Mastercard Incorporated (MA $551.89)
- $551.89 P/E (TTM): 35.21X Cap: $495.59B
- View MA Profile
- View Questions on MA
Canadian National Railway Company (CNR $137.07)
- $137.07 P/E (TTM): 17.86X Cap: $84.36B
- View CNR Profile
- View Questions on CNR
Linamar Corporation (LNR $87.28)
- $87.28 P/E (TTM): 21.27X Cap: $5.22B
- View LNR Profile
- View Questions on LNR
Algonquin Power & Utilities Corp. (AQN $8.95)
- $8.95 Cap: $6.88B
- View AQN Profile
- View Questions on AQN
Kinaxis Inc. (KXS $123.31)
- $123.31 P/E (TTM): 73.06X Cap: $3.46B
- View KXS Profile
- View Questions on KXS
- View Reports on KXS
Western Forest Products Inc. (WEF $15.73)
- $15.73 Cap: $179M
- View WEF Profile
- View Questions on WEF
Magna International Inc. (MG $72.12)
- $72.12 P/E (TTM): 13.78X Cap: $20.32B
- View MG Profile
- View Questions on MG
- View Reports on MG
Block Inc. Class A (SQ)
- P/E (TTM): 59.56X Cap: $53.89B
- View SQ Profile
- View Questions on SQ
BMO Equal Weight US Banks Hedged to CAD Index ETF (ZUB $40.67)
- $40.67 P/E (TTM): 12.09X Cap: $351M
- View ZUB Profile
- View Questions on ZUB
WELL Health Technologies Corp. (WELL $3.91)
- $3.91 Cap: $1.04B
- View WELL Profile
- View Questions on WELL
- View Reports on WELL
TD Science & Technology Fund - D Series (TDB3098 $40.75)
- $40.75 P/E (TTM): 30.0X Cap: $564M
- View TDB3098 Profile
- View Questions on TDB3098
TD Health Sciences Fund - D Series (TDB3099 $23.21)
- $23.21 P/E (TTM): 23.7X Cap: $364M
- View TDB3099 Profile
- View Questions on TDB3099
Geyser Brands Inc. (GYSR)
- Cap: $3M
- View GYSR Profile
- View Questions on GYSR
Lightspeed Commerce Inc. Subordinate Voting Shares (LSPD $12.76)
- $12.76 Cap: $1.73B
- View LSPD Profile
- View Questions on LSPD
- View Reports on LSPD
CrowdStrike Holdings Inc. (CRWD $377.16)
- $377.16 Cap: $95.08B
- View CRWD Profile
- View Questions on CRWD
Unity Software Inc. (U $23.21)
- $23.21 Cap: $9.93B
- View U Profile
- View Questions on U

Q: Hi Peter and staff,
Thanks for the great information that you guys provide.
These are the holdings in my wife's TFSA account. I have owned CNR since March of 2020 and have done quite well but I'm wondering if this stock has reached the top of the price range and it's time to move on. The average Price Target is $165. Do you think that CNR still has upside or can you name two stocks to replace it.

Thanks and have a great day
Joe

Read Answer Asked by Joe on October 22, 2021